Sandbox:Aditya

Jump to navigation Jump to search

Historical perspective

  • In 1904 Guillemot first put weight to the theory that aspirated oropharyngeal organisms were responsible for cause of lung abscess[1]
  • In 1920-1930 Harold Neuhof, was the first thoracic surgeon to develop a valid and reliable therapeutic concept of new one-stage open drainage operation for surgery of acute pulmonary abscess.[2]
  • In 1938 first cutaneous drain of lung abscess was performed.[3]
  • In 1942 Brock added evidence in stating that aspirated contents gravitated to the dependents part of the lungs
  • In 1946,owing to the advent of antibiotics, and treatment of acute putrid lung abscess with penicillin showed good results and henceforth patients received antibiotics rather than surgical procedures[2]

Pathophysiology

Pathogenesis

  • Aspiration of anerobic bacteria from the oro-pharnynx, secondary to altered level of consciousness, absent gag reflex or inability to swallow is the primary pathogenesis in the development of lung abscess.
  • In healthy individuals, defense mechanisms cope up with the small amounts of aspirates with no effects, however, in conditions like alcoholism, diabetis mellitus, and immunocompromised state these defense mechanisms can be compromised leading to decreased activity of alveolar macrophages and mobility of leukocytes predisposing patients to developng abscess. [4].
  • In secondary lung abscess, abscess formation depends on the underlying lung disease and predisposing factors such as bronchial obstruction from benign or malignant intrabronchial lesions or extrinsic compression of bronchus (eg:middle lobe syndrome) results in distal abscess formation due to decrease oropharyngeal clearance due to decreased clearance mechanisms and favouring abscess formation.
  • Localization of the aspirate results in pneumonitis [5]
  • Inflammatory mediators along with bacterial toxins and proteolytic enzymes from neutrophils are released leading to rupture of small blood vessels resulting in the formation of colliquative necrosis [6]

Location of abscess

  • The right lung is more commonly affected than the left lung because is of it more angulation than the left bronchi.
  • The most common location is the posterior segment of the right apical lobe or apical segments of lower lobes of both the lungs.[7]
  • Lateral part of the posterior segment of upper lobe of the right lung is more commonly involved in alcoholics.

Genetics

  • Congenital diseases such as cystic fibrosis, vasculitis, pulmonary sequestration and bronchial cysts are associated with increased the risk of lung abscess in children.[8]

Gross Morphology

  • In acute lung abscess, the lesions are well circumscribed filled with necrotic debris and do not demonstrate well-defined borders with the surrounding lung parenchyma.[9]
  • In chronic long standing abscess, the lesions are irregular and filled with grayish thick debris.

Microscopic Findings

  • In acute lung abscess, neutrophilic granulocytes are demonstrated with dilated blood vessels and inflammatory edema.[9]
  • In chronic lung abscess, biopsy specimen demonstrates lymphocytes, plasma cells, and histiocytes around a layer of pyogenic membrane surounding the abscess cavity which is filled with pus.

Classification

  • Lung abscess can be classified into three types based on duration of symptoms, etiology and mode of spread as follows:

Based on duration of symptoms

  • Acute: If the duration of symptoms is less than 4-6 weeks before presenting to medical care.[10]
  • Chronic: If the symptoms persists for more than 6 weeks.

Based on Etiology

  • Primary: When the abscess develops after lung infection in previously healthy persons or in patients prone to aspiration [11]
  • Secondary: Abscess formation in patients due to complications of a co-existing lung disease such as post obstructive process (bronchial obstruction due to tumor , foreign body or enlarged lymphnodes) and systemic process resulting in decreased immune response like HIV, and patients on immunosuppressantss and corticosteroids.

Based on mode of spread

Bronchiogenic: Abscess formation is due to aspiration and inhalation.[10]

  • Aspiration of oropharyngeal secretions
  • Bronchial obstruction by tumor
  • Foreign body, congenital malformations, and enlarged lymph nodes

Hematogenic: Abscess formation due to dissemination of causative agents from other infected sites

  • Infective endocarditis
  • Abdominal sepsis
  • Septic thromboembolism

Risk Factors

Factors resulting in altered level of consciousness and decreased immune response play a key role in the development of lung abscess :

Common Risk Factors

  • Alcoholism[12]
  • Seizure disorder
  • Artificial ventilation
  • Coma
  • Neuromuscular disorders with bulbar dysfunction
  • Nocturnal aspiration
  • Bronchial obstruction
  • Gingivo-dental sepsis
  • Diabetes mellitus
  • Immunosuppression

Less Common Risk factors

  • Drug abuse
  • Malnutrition
  • Mental retardation
  • Gastroesophageal reflux disease

Causes

Lung abscess may be caused by either by a necrotizing infection of lung parenchyma or necrosis of an infarcted lung tissue and cavitation in the necrotic tissue by malignant lesions

Microbiology

  • About 90% of the lung abscess is caused by polymicrobial infection.[13] [14]
  • Anaerobes are the predominant pathogens involved in primary lung abscess, followed by Streptococcus pneumoniae.
  • Klebsiella pneumoniae is the more commonly seen in alcoholics.[15]
  • Staphylococcus aureus is the most common pathogen responsible for lung abscess in children with cystic fibrosis.[16]

The following table elaborates the most common etiological pathogens responsible for lung abscess [17]

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polymicrobial
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bacterial
 
 
 
 
 
 
 
 
 
 
Fungal
 
 
 
Parasites
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anerobic
 
 
 
 
 
 
 
 
 
Aerobic
 
 
 
 
Histoplasma
Blastomyces
Coccidoides
Aspergillus
Cryptococcus
 
 
 
Entamoeba histolytica
Paragominus Westermani
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gram Negative
 
 
 
Gram Positive
 
 
 
Gram Positive
 
 
 
Gram Negative
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bacteroides fragilis
Fusobacterum capsulatum
Fusobacterum necrophorum
 
 
 
Peptostreptococcus
Microerophilic streptococci
Actinomyces
 
 
 
Staphyloccocus areus(including MRSA)
Streptococcous Pneumonia
Streptococcus Pyogens
Nocardia
 
 
 
Klebsiella pneumoniae
Heamophillus influenza type B
Pseudomonas aeurongiosa
Escherichia coli
Legionella Pneumophilia
Acinetobacter spp

Natural History, Prognosis and Complications

Natural History

  • Lung abscess is most commonly seen in the fourth decade of life in patients with risk factors or underlying other lung disorders.[18]
  • Clinical manifestations include fever, productive cough, pleuritic chest pain and occasional episodes of hemoptysis, typically developing 8-14 days after aspiration.
  • The progression of the abscess is dependent on two factors: immune status of the patient and antibiotic therapy.
  • In immunocompetent patients with adequate treatment abscess resolves forming a granulation tissue scar, without treatment the abscess progressively worsens and can result in septicemia, hemorrhage, and death.

Prognosis

The prognosis of lung abscess is good with appropriate antibiotic treatment with a high success rate. The outcomes depend on the other associated conditions underlying lung abscess. The mortality rate of lung abscess is as high as 75% in patients with underlying immunocompromised state and bronchial obstruction favoring poor prognosis The following factors are considered to be associated with poor prognosis among patients.[19]

  • Large size cavities(>6cms)
  • Old age
  • Necrotizing pneumonia
  • Prolonged symptoms
  • Abscess due to aerobic bacteria and hospital acquired
  • Bronchial obstruction due to tumors or foreign body (secondary abscess)
  • Immuncompromised individuals

Complications

Without treatment, lung abscess can result in the following complications:

  • Hemorrhage [20]
  • Pyopneumothorax
  • Pleural empyema[21]
  • Fibrosis and calcification of lung tissue
  • Mediastinal, pleural and cutaneous fistulas
  • Sepsis

Diagnosis

History and symptoms

Patients with lung abscess can present with the history of following important findings.

Symptoms

Patients with lung abscess present with the following symptoms. More common symptoms

  • Fever with chills,
  • Cough (initially non-productive and progress to productive)[22] [23]
  • Pleuritic chest pain
  • Discolored, foul-smelling sputum is seen in anaerobic infections.
  • Rapid fever with rapid progression of symptoms is seen with aerobic bacteria and indulent and gradual progression in other causative agents.

Less common symptoms

  • Dyspnea
  • Weight Loss
  • Anemia and fatigue is more commonly seen in anaerobic infections
  • Clubbing of fingers.

Physical examination

The common physical examination findings in patients with lung abscess include:

General examination:

  • Respiratory distress
  • Fever with chills may be present
  • Poor oral hygiene with gingivitis, dental erosions or poor dentition.
  • Digital clubbing is seen in chronic lung abscess

Respiratory system

  • Dullness to percussion
  • Decreased breath sounds on the side of lung abscess
  • Bronchial breath sounds on auscultation
  • Inspiratory crackles
  • Localised crepitations

Laboratory findings

Diagnosis of lung abscess is made based on clinical symptoms, physical examination, radiographic studies and bacterial culture.

Microbial testing

  • To identify etiologic agent and to initiate appropriate antibiotic therapy
  • When patients present with typical symptoms of fever with chills, cough with purulent sputum for more than 2 weeks and with risk factors of aspiration it is appropriate to suspect anaerobes as a possible pathogen.[24]
  • Cultures of the sputum for anaerobic bacteria is not recommended because of its contamination by the normal flora in the oral cavity. The only cultures that can give a positive result for anaerobes is empyema
  • It is often difficult to get uncontaminated sputum specimens as both upper respiratory tract and lower respiratory tract along oral cavity is contaminated with various flora.
  • The only methods available for obtaining uncontaminated specimens are trans-tracheal aspirates (TTA), transthoracic needle aspirates (TTNA), culture of pleural fluid, or blood cultures are recommended before administration of empiric antibiotics
  • Sputum analysis and culture is recommended for finding out aerobic and other causative agents of lung abscess.The contamination of the sputum sample can be minimized by
    • Obtaining the sputum sample prior to antibiotic treatment.[25]
    • Rinsing the mouth prior to expectoration
    • NPO for one to two hours prior to expectoration
    • Inoculation of the culture media immediately after the specimen is obtained


 
 
 
 
 
 
 
 
Sputum Analysis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acid Fast Stain
 
Culture on Sabourad's medium
 
Direct Microscopic Examination for sulphur granules
 
Gentain Voilet Stain
 
Aerobic Culture
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tuberculosis
 
Yeast and Fungi
 
Actinomyces and other mycelia of Fungi
 
Fusiform Bacteria and Spirochetes
 
Pyogenic organsims
  • Interpretation of sputum cultures in these cases must take into account the clinical features of the patient, concentrations of the different organisms found in the culture and Gram stain, and the antibiotics the patient has received.

Chest Xray

  • An irregularly shaped thick walled cavity with an air-fluid level is typically seen in lung abscess on chest xray.
    Lung abscess
    Lung abscess
    [26]
  • Lung abscesses as a result of aspiration most frequently occur in the posterior segments of the upper lobes or the superior segments of the lower lobes. [27] [28]
  • The extent of the air-fluid level within a lung abscess is often the same in posteroanterior or lateral views.
  • Anaerobic infection may be suggested by cavitation within a dense segmental consolidation in the dependent lung zones.
  • Lung infection with a virulent organism results in more widespread tissue necrosis
  • Up to one-third of lung abscesses may be accompanied by an empyema.[29]
  • Repeat chest radiographs must be obtained to determine the response of antimicrobial therapy.

CT Scan

  • CT is helpful in differentiating the cavitation of abscess that cannot be clearly delineated on the chest radiograph from empyema and other cavitary lesions.[29]
  • On CT scan lung abscess is visualized as a rounded radiolucent lesion with a thick wall and ill-defined irregular margins, and is located within the parenchyma compared with loculated empyema, which may be difficult to distinguish on chest radiographs. [30]
  • Computed tomography (CT) lung is considered as the gold standard not only for the diagnosis of lung abscess but also for guiding therapeutic procedures such as trans-thoracic drainage of localized lung abscess .[31]
  • CT scan is very helpful in excluding endobronchial obstruction due to malignancy or foreign body and provides additional information about size and location of the abscess,

Ultrasound

  • Ultrasound has a minimal role in diagnosing lung abscess .
  • Lung abscess appears as a rounded hypoechoic lesion with an outer margin on ultrsound.
  • Lung abscesses which are peripheral and with pleural contact or included inside a lung consolidation are detectable using bedside lung ultrasonography.

Medical treatment

  • The mainstay of management for lung abscess is : hospital admission for chest drain and systemic antibiotics
  • Empiric treatment should be commenced after culture samples are obtained.
  • The choice of empiric antibiotics should be determined on the basis of the possible risk of multi-drug resistant causative bacteria, and culture results.
  • Clindamycin (600 mg i.v. every 8 hours followed by 150-300 mg every 6 hours p.o.) is considered the first-line drug of choice for anaerobic lung infections.[32] [33]
  • With the emergence of resistance of anaerobic bacteria and microaerophilic Streptococci mostly to penicillin G and more rarely to clindamycin, due to β-lactamase production, β-lactam/β-lactamase inhibitor combinations (amoxicillin/clavulanate, ampicillin/sulbactam) presented as highly effective agents for community-acquired lung abscesses.[34] [35]
    • This antimicrobial regimen provides adequate coverage against gram (+), gram (-) Enterobacteriaceae (e.g. Klebsiella pneumonia, Enterobacter) and anaerobic bacteria.[36]
  • A possible therapeutic alternative is the combination of a 2nd (cefuroxime, cefoxitin) or 3rd generation cephalosporin (ceftriaxone) with clindamycin or metronidazole.
  • Monotherapy with metronidazole should be avoided due to inadequate coverage for aerobic and microaerophilic Streptococci, such as Streptococcus milleri.[37]
  • Linezolid (initial i.v.administration 600 mg twice daily and subsequent oral administration after clinical improvement) is preferred in cases of lung abscess caused by MRSA.[38]
  • An alternative choice is vancomycin (15 mg/kg x2 i.v., with dose adapted according to optimal serum levels (15-20 mcg/ml) and renal function). Low daptomycin concentrations achieved in lung tissue renders daptomycin inadequate for lower respiratory infections.[39]
  • Clinical improvement is reflected in the subsidence of fever (within the first 3-4 days) and complete defervescence within 7-10 days.Persistent fever can be explained by treatment failure due to uncommon pathogens (multidrug resistant common bacteria, mycobacteria, fungi)or by the presence of an alternative diagnosis (e.g. endobronchial obstruction, vasculitis) that requires further diagnostic workup (e.g. bronchoscopy, transdermal or surgical lung biopsy).[40]
  • The duration of treatment with antibiotics is not well defined, according to many experts, the optimal duration of antimicrobial therapy is 3-6 weeks, whereas others take the timing of radiological response into consideration. [40]
  • In that case, the length of antibiotic treatment depends on complete radiological resolution or stabilization to a small residual lesion.
  • Treatment interval may then be prolonged to several months (more than 2),6 especially when the initial lesion is of large size (maximum diameter more than 6cm).


Medical Therapy for the management of Lung Abscess
Empiric Therapy
  • Clindamycin
  • Penicillin with betalactamase inhibitor
Non responsive to initial therapy and based on culture reports
  • MRSA: Linezolid or Vancomycin
  • Cephalosporin with clindamycin or metronidazole

Surgical Therapy

Indications

  • Abscess > 6 cm in diameter
  • If symptoms last more than 12 weeks with appropriate therapy

Surgical Options

  • Options for surgery includes: Chest tube drainage and surgical resection of the lung abscess with the surrounding lung tissue

Chest tube drainage

  • Percutaneous and endoscopic drainage techniques are considered as a first-line management, especially for patients who are not candidates for surgery [41]

Percutaneous drainage

Type of chest drain Indications Procedure Complications Advantages
Percutaneous thoracocentesis
  • It is the treatment of choice for patients who have failed to respond to antibiotic therapy .[42]
  • Patients who are unsuitable for surgical intervention (e.g. due to severe immunodeficiency or mechanical ventilation).
  • Lung abscesses with diameters greater than 4-8 cm
  • Performed under fluoroscopic, ultrasound or computed tomography guidance.(CT is generally preferred due to additional information provided about location, content and wall-thickness of the abscess.)
  • Two techniques of insertion of chest tube employed: Seldinger, and Trochar
  • Seldinger technique of insertion the tube is considered as it is  safer and it permits greater control in the positioning of the drainage tube and  is accompanied by fewer complications[43]
  • Chest tube drainage with trocar is highly effective surgical procedure and is recommended for thoracic surgeries
  • Drainage duration varies but a minimum of 4-5 weeks are required and is done according to radiographic findings.Chest tubes should not be flushed in order to avoid bronchogenic spread of the pus.[41]
  • The usage of intra-cavitary fibrinolytic agents (streptokinase, urokinaze) is not recommended, due to possibility of bronchopulmonary or bronchopleural fistula can occur.[44]
      
  • Technique related includes :advancing of the guidewire through the thicked-wall abscess may cause bending or rupture of the guidewire or the catheter.[45]
  • Hemothorax, hemoptysis, pyopneumothorax and fistula formation between the pleural cavity and the abscess resulting in empyema.
  • Less significant complications are those related to bending or leaking of the drainage catheter.
  • These techniques demonstrated benefits even in patients without contraindications to surgery. More specifically, cases of primary lung abscess that were treated by Yellin A et al during a 5-year period (1978-1982) underwent successful percutaneous drainage, without any complications or relapse after 2-5 years of monitoring.[46]
  • Percutaneous drainage of lung abscesses is characterized by high therapeutic effectiveness and preservation of functional lung tissue, it is a minimally invasive method with fewer complications and lower mortality rates (approximately 4%) in comparison to surgical management.[47]
  • In case of pleural space obliteration, with peripheral localization of lung abscess, it is possible to perform pneumostomy or cavernostomy-open drainage of abscess(Monaldi procedure) but it is limited due to it invasiveness.
Endoscopic thoracic drainage
  • Pateints with poor general condition,
  • Coagulopathies
  • For the abscesses with central locations in lungs.
  • A guidewire is inserted into the cavity through the working channel of a flexible bronchoscope.Once guidewire location has been ascertained by fluoroscopy, a 7 French pigtail catheter is advanced.
  • If infusion of contrast medium via the catheter confirms its proper positioning, the guidewire and bronchoscope are withdrawn and the catheter tip is stabilized at the nasal wall.
  • Subsequently, the cavity is flushed daily with normal saline solution through the catheter, along with antibiotic infusions (e.g. gentamicin or amphotericin in confirmed fungal infections).[48]
  • The catheter remains open for the rest of the day, thus ensuring the drainage of the abscess.
  • In a small number of patients with recurrent lung abscesses, endoscopic drainage was performed with the help of laser.[49]
  • The catheter is inserted through a bronchoscope and laser is used in order to perforate the wall of the abscess through the airway and to lead the catheter inside the cavity. The catheter is removed after 4-6 days with immediate improvement of clinical status and radiological imaging within the first 24 hours
  • Spillage of necrotic detritus in other parts of the lungs

Surgical Intervention

  • Surgery is considered in about 10% of the patients with unsuccessful medical therapy and thoracocentesis.

Indications

  • Hemoptysis,
    • Prolonged sepsis and febricity,[50]
    • Bronchopleural fistula,
    • Rupture of abscess in the pleural cavity with pyopneumothorax/empyema.
    • Unsuccessfully treated lung abscess more than 6 weeks,
    • Suspicion of cancer,
    • Cavitary lesion larger than 6 cm,
    • Leukocytosis despite the use of antibiotics.

Surgical resection

  • The surgical approach is thoracotomy and the extent of surgical resection depends on the size of the underlying lesion. [50]
  • Lobectomy is the most common type of surgical resection. Segmentectomies are performed in smaller abscesses (<2 cm), whereas a pneumonectomy should be performed in the presence of multiple abscesses or gangrene. [51],[52]
  • Open surgical drainage is employed either by creating a pouch-like cavity communicating with the thoracic wall through limited rib resection in case of thoracotomy contraindication.
  • When sepsis cannot be controlled with conservative measures and in conditions that prohibit resection, debridement of the dead tissue is followed by immediate filling of the cavity with highly vascular tissue, or debridement and cavity fistulization into the pleural space followed by drainage by means of a chest tube is proposed.
  • When the chronic inflammatory process of pulmonary infection causes incomplete re-expansion of the remaining lobes, it is quite possible that a portion of the pleural space will remain empty. Some thoracic surgeons recommend filling that space with a large pedicled ipsilateral latissimus dorsi muscle flap or omentum.
  • In addition, bronchial stump reinforcement with a pedicled intercostal muscle flap or other highly vascular tissue may prevent the formation of a bronchopleural fistula.
  • Cross-contamination of contralateral lung is the main complication to be feared of during surgery. Placement of a double-lumen endotracheal tube, prone positioning of the patient and artificial obstruction of the main bronchus before removing the abscess are the usual measures for preventing cross-contamination.
  • Recently, a thoracoscopic technique (Video assisted thoracoscopic surgery: VATS) for abscess debridement and drainage has been effectively implemented in a small number of patients.53

Differential diagnosis

Non-infectious

causes of lung cavities

Differntiating Features Differntiating lab findings Diagnosis

confirmation

  • Malignancy (Primary lung cancer)[53]
  • Elderly male or female [53]
  • Associated with a low-grade fever, absence of leukocytosis, minimal systemic complaints,
  • Absence of factors that predispose to gastric content aspiration, no response to antibiotics within 10 days,
  • Follows a deteriorating course.
  • Hemoptysis is commonly associated with bronchogenic carcinoma
  • Weight loss,fatigue,
  • A coin-shaped lesion with thick wall(>15mm) is seen on X-ray with less ground glass opacities.[54] [55]
  • Sputum cytology shows malignant cells
  • CT and bronchoscope identifies the lesions
  • Biopsy confirms it
  • Tuberculsosis
  • Systemic symptoms of fatigue, malaise, anorexia, and weight loss, as well as a low-grade fever with night sweats
  • Xray shows cavities in the upper lobe of the lung
  • On CT cavitating lesions are seen in the upper lobes accompanied by parenchymal infiltrates .
  • Sputum smear and culture in Lowenstein-Jensen media is positive for acid-fast bacilli.
Necrotizing Pneumonia Acute, fulminant infection with rapid progression Multiple cavities are seen on xray

Pleural effusion and empyema are common findings.

  • Granulomatosis with polyangiitis (Wegener's)[56]
  • Upper respiratory tract: perforation of nasal septum,chronic sinusitis, otitis media,mastoditis.[57]
  • Lower respiratory tract: hemoptysis, cough,dyspnea.
  • Renal: hematuria, red cell casts
  • Pulmunory nodules with cavities and infiltrates are a frequent manifestation on CXR.
  • Positive for P-ANCA
  • Biopsy of the tissue involved shows necrotizing granulomas [56]
  • Sarcoidosis
  • More common in African-American females.
  • Often asymptomatic except for enlarged lymph nodes.[58]
  • Associated with restrictive lung disease (interstitial fibrosis),
  • Erythema nodosum,
  • Lupus pernio (skin lesions on face resembling lupus),
  • Bell palsy,
  • Epithelioid granulomas containing microscopic Schaumann and asteroid bodies,
  • Uveitis,
  • Hypercalcemia
  • On chest Xray bilateral adenopathy and coarse reticular opacities are seen.
  • CT of the chest demonstrates extensive hilar and mediastinal adenopathy
  • Additional findings on CT include fibrosis (honeycomb, linear, or associated with bronchial distortion), pleural thickening, and ground-glass opacities.[59]
  • Non-caseating granuloma on lung biopsy
  • Bronchiolitis obliterans (Cryptogenic organizing pneumonia)[60][61]
  • It is a pathological diagnosis
  • And is triggered by drug or toxin exposure, autoimmune diseases,viral infections, or radiation injury but is most often idiopathic
  • Presents with fever, cough, weight loss, and dyspnea over weeks to months, similar to many infectious diseases[62]
  • Common appearance on CT is patchy consolidation,often accompanied by ground-glass opacities and nodules.[63]
  • Langerhan'scell histiocytosis[64]
  • Exclusively afflicts smokers, with a peak age of onset of between 20 and 40 years.
  • Clinical presentation varies, but symptoms generally include months of drycough, fever, night sweats, and weight loss.
  • Thin-walled cystic cavities are the usual radiographic manifestation, observed in over 50% of patients by either plain chest radiography or computed tomography scans.[65]
  • Biopsy of the lung
Infectious agent Patient characteristics, comorbidities,

and/or risk factorsa

Epidemiology Radiological findings

Bacteria

  • Actinomyces spp.[66]
  • Male predominance,
  • Poor oral hygiene
  • Alcohloics
  • Normal inhabitant of oral cavity,
  • Gastrointesinal tract, and female reproductive tract
  • Commonly involves infection of neck,thoracic region and abdomen pelvis.[67]
  • Infection of lungs is commonly resulted from the aspiration of actinomyces load from neck infection
  • Pleural mass with wavy perisoteal reaction involving ribs is seen at the site of involvement on Xray
  • Cavitary lesions are only appreciated on CT scan .[68]
  • Klebsiella spp.
  • Alcoholism, corticosteroid use,
  • Hematologic malignancy,
  • Male predominance
  • Nosocomial and community acquisition
  • Bulging interlobar fissures, unilateral/bilateral infiltrates, abscess, cavitation
  • Nocardia spp.
  • Chronic obstructive pulmonary disease,
  • Corticosteroid use,
  • HIV/AIDS (rare),
  • Malignancy,posttransplant
  • Soil organism
  • Lobar consolidation, nodular infiltrate, solitary mass, cavitation
  • Staphylococcus aureus
  • Debilitated hospitalized patients,
  • Immunocompetent patients with extrapulmonary staphylococcal infection (e.g., skin infection with community-acquired MRSA)
  • Community acquired or nosocomial
  • Consolidation, pneumatocele, cavity
  • Mycobacterium tuberculosis
  • Birth or prolonged residence in area of endemicity (developing world),
  • Diabetes mellitus,
  • Head and neck cancer,
  • Hematologic malignancy,
  • HIV/AIDS,
  • Immunosuppressive therapy,tumor necrosis factor alpha antagonist use
  • Spread from person to person through inhalation of droplet nuclei;
  • More prevalent in developing countries
  • Upper lobe infiltrates, cavity,miliary pattern, tuberculoma, hilar lymphadenopathy

Fungus

  • Aspergillus spp.
  • Hematologic malignancy,
  • HIV/AIDS, immunosuppressive therapy, malnutrition,
  • Neutropenia posttransplant,
  • Underlying pulmonary disease (asthma, cystic fibrosis)
  • For invasive aspergillosis; alcoholism, chronic obstructive pulmonary disease, collagen vascular disease, diabetes mellitus, low-dose corticosteroid use, malnutrition, pnemoconiosis for semi-invasive; and prior tuberculosis or other cavity causing disease for aspergilloma
  • Saprophytic fungi that grow on organic debris;
  • Potential environmental exposure for hospitalized high-risk patients
  • Invasive aspergillosis: macronodules, consolidation,halo sign, air-crescent sign,cavitation.
  • Semi-invasive aspergillosis: progressive or chronic infiltrate, cavity with or without air-crescent sign,
  • Aspergilloma:fungus ball in preexisting cavity
  • Blastomyces dermatitides
  • black race, diabetes mellitus,
  • Male gender, outdoor activity,
  • Prior history of pneumonia
  • Endemic to Mississippi and Ohio River valleys, Great Lakes, and St. Lawrence River region;
  • Also found in parts of Mexico, Central and South America, Africa, and the Middle East
  • Acute: Patchy alveolar opacities nodular densities;
  • Chronic: Fibronodular upper lobe disease,smooth-walled cavities, solitary mass lesion, volume loss, calcification, fibrosis, miliary pattern
  • Coccidioides immitis
  • Corticosteroid use,
  • Diabetes mellitus,
  • HIV/AIDS, malignancy,
  • Black or Filipino race/ethnicity,
  • Organ transplant
  • Endemic to the southwestern United States and Mexico;
  • Also be associated with occupational exposure (construction, archeological excavation) or extreme weather conditions in an area(i.e., duststorm)
  • Acute: patchy opacities, multilobar consolidation, thick-walled cavities, pleural effusion, hilar lymphadenopathy;
  • Chronic: thinwalled cavities, pleural effusion, pneumothorax, single or multiple nodules
  • Cryptococcus spp.
  • Corticosteroid use,
  • Diabetes mellitus,
  • HIV/AIDS,hematologic malignancy,
  • Organ transplant,
  • Sarcoidosis
  • Isolated from soil contaminated by pigeon and chicken excreta
  • solitary or multiple nodules, alveolar consolidation,interstitial pattern, cavitation,lymphadenopathy, pleural effusion
  • Histoplasma capsulatum
  • Heavy equipment operators,
  • Poultry breeders
  • Chronic obstructive pulmonary disease,
  • Middle-aged men
  • Endemic to the Ohio and Mississippi River valleys,Virginia, and Maryland;
  • Grows well in soil that has been enriched by bird excreta
  • Acute: scattered patchy or diffuse interstitial opacities, solitary pulmonary nodule, miliary pattern, hilar or mediastinal lymphadenopathy;
  • Chronic:cavitation
  • Pneumocystis jirovecii
  • Autoimmune disorders,
  • Corticosteroid use,
  • Hematologic malignancy,
  • HIV/AIDS,
  • Posttransplantation
  • Ubiquitous fungi
  • Bilateral alveolar/interstitial infiltrates, solitary or multiple nodules, pneumothorax, cavity,

Parasites

  • Echinococcus granulosus
  • Endemic to Mediterranean region, Middle East, Africa, Latin America, southwest United States, southern Europe,
  • Largely in livestockrearing areas; dogs are the definitive host
  • Spherical homogenous masses with smooth borders surrounded by normal lung tissue, bullae,calcifications, cavity
  • Paragonimus westermani
  • Zoonosis that is endemic to Japan, the Korean peninsula, the Philippines, and parts of China;
  • May be acquired through eating freshwater crabs and raw boar meat
  • Nodules, mediastinal lymphadenopathy, pleural effusion

Primary prevention

Effective measures for the primary prevention of lung abscess include:

  • Prevention of aspiration in high-risk individuals by providing proper attention towards airway protection, minimal sedation, and proper positioning of patients with elevation of the head in hospitalized patients.
  • Prophylactic antibiotics against certain pathogens in at-risk patients e.g.recipients of bone marrow or solid organ transplants or patients whose immune systems are significantly compromised by HIV infection must be given.
  • Improving oral hygiene and proper dental care in elderly and debilitated patients also helps in decreasing the risk of anaerobic lung abscess.


Pathogens Age group specific therapy
Adult
Empiric Anaerobes and microaerophilic streptococci ·         Ampicillin +sulbactum  3g IV q6h

(or)

·         Imipenem+cilastin  500 mg IV q6h

(or)

·         Meropenem    1-2 g IV q8h

2nd alternnative Clindamycin  IV 600 mg q8h

150 to 300 mg orally four times daily

Pathogen directed MSSA Nafcillin 2 g IV q4h OR Oxacillin 2 g IV q4h OR Cefazolin 2 g IV q8h
MRSA Linezolid 600 mg q12h IV/PO ± Rifampin 300 mg po/IV bid
Actinomyces Intravenous penicillin G (10 to 20 million units daily in divided doses every four to six hours) for 4 to 6 weeks, 
Nocardia .spp TMP-SMX 15 mg/kg IV of the trimethoprim component per day in three or four divided doses 

PLUS

Amikacin 7.5 mg/kg IV every 12 hours 

Fungi Amphotericin B  3-5mg/kg/day/IV
Parasite Albendazole is dosed 10 to 15 mg/kg per day in two divided doses; the usual dose for adults is 400 mg twice daily.

one to three months may be appropriate, depending clinical factors; up to six months may be required.

† Risk factors for MRSA include:

Recent hospitalization, residence in a long-term care facility, recent antibiotic therapy, HIV infection, men who have sex with men, injection drug use, hemodialysis, incarceration, military service, sharing needles, razors, or other sharp objects, sharing sports equipment, diabetes, prolonged hospital stay, swine farming

References

  1. Lima, Mario (01/24/2011). Pediatric thoracic surgery Softcover reprint of hardcover 1st ed. 2009. Harvard Medical School: Springer London. p. 145. ISBN 978-8847052017. Check date values in: |date= (help)
  2. 2.0 2.1 Neuhof H, Hurwitt E (1943). "ACUTE PUTRID ABSCESS OF THE LUNG : VII. RELATIONSHIP OF THE TECHNIC OF THE ONE-STAGE OPERATION TO RESULTS". Ann. Surg. 118 (4): 656–64. PMC 1617784. PMID 17858299.
  3. Wali SO (2012). "An update on the drainage of pyogenic lung abscesses". Ann Thorac Med. 7 (1): 3–7. doi:10.4103/1817-1737.91552. PMC 3277038. PMID 22347342.
  4. Green LH, Green GM (1968). "Differential suppression of pulmonary antibacterial activity as the mechanism of selection of a pathogen in mixed bacterial infection of the lung". Am. Rev. Respir. Dis. 98 (5): 819–24. doi:10.1164/arrd.1968.98.5.819. PMID 5683476.
  5. Brook I (2004). "Anaerobic pulmonary infections in children". Pediatr Emerg Care. 20 (9): 636–40. PMID 15599270.
  6. Tsai YF, Ku YH (2012). "Necrotizing pneumonia: a rare complication of pneumonia requiring special consideration". Curr Opin Pulm Med. 18 (3): 246–52. doi:10.1097/MCP.0b013e3283521022. PMID 22388585.
  7. Bartlett JG (1993). "Anaerobic bacterial infections of the lung and pleural space". Clin. Infect. Dis. 16 Suppl 4: S248–55. PMID 8324127.
  8. Canny GJ, Marcotte JE, Levison H (1986). "Lung abscess in cystic fibrosis". Thorax. 41 (3): 221–2. PMC 460300. PMID 3715782.
  9. 9.0 9.1 Kuhajda I, Zarogoulidis K, Tsirgogianni K, Tsavlis D, Kioumis I, Kosmidis C, Tsakiridis K, Mpakas A, Zarogoulidis P, Zissimopoulos A, Baloukas D, Kuhajda D (2015). "Lung abscess-etiology, diagnostic and treatment options". Ann Transl Med. 3 (13): 183. doi:10.3978/j.issn.2305-5839.2015.07.08. PMC 4543327. PMID 26366400.
  10. 10.0 10.1 Puligandla PS, Laberge JM (2008). "Respiratory infections: pneumonia, lung abscess, and empyema". Semin. Pediatr. Surg. 17 (1): 42–52. doi:10.1053/j.sempedsurg.2007.10.007. PMID 18158141.
  11. Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
  12. Hagan JL, Hardy JD (1983). "Lung abscess revisited. A survey of 184 cases". Ann. Surg. 197 (6): 755–62. PMC 1352910. PMID 6859981.
  13. Cesar L, Gonzalez C, Calia FM (1975). "Bacteriologic flora of aspiration-induced pulmonary infections". Arch. Intern. Med. 135 (5): 711–4. PMID 28705.
  14. Bartlett JG (2012). "Anaerobic bacterial infection of the lung". Anaerobe. 18 (2): 235–9. doi:10.1016/j.anaerobe.2011.12.004. PMID 22209937.
  15. Wang JL, Chen KY, Fang CT, Hsueh PR, Yang PC, Chang SC (2005). "Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes". Clin. Infect. Dis. 40 (7): 915–22. doi:10.1086/428574. PMID 15824979.
  16. "www.iosrjournals.org" (PDF).
  17. Lorber B, Swenson RM (1974). "Bacteriology of aspiration pneumonia. A prospective study of community- and hospital-acquired cases". Ann. Intern. Med. 81 (3): 329–31. PMID 4850729.
  18. Adebonojo SA, Osinowo O, Adebo O (1979). "Lung abscess: a review of three-years' experience at the University College Hospital, Ibadan". J Natl Med Assoc. 71 (1): 39–43. PMC 2537236. PMID 423274.
  19. Hirshberg B, Sklair-Levi M, Nir-Paz R, Ben-Sira L, Krivoruk V, Kramer MR (1999). "Factors predicting mortality of patients with lung abscess". Chest. 115 (3): 746–50. PMID 10084487.
  20. Philpott NJ, Woodhead MA, Wilson AG, Millard FJ (1993). "Lung abscess: a neglected cause of life threatening haemoptysis". Thorax. 48 (6): 674–5. PMC 464615. PMID 8346503.
  21. Schattner A, Dubin I, Gelber M (2016). "Double jeopardy - concurrent lung abscess and pleural empyema". QJM. 109 (8): 545–6. doi:10.1093/qjmed/hcw078. PMID 27208219.
  22. Chan PC, Huang LM, Wu PS, Chang PY, Yang TT, Lu CY, Lee PI, Chen JM, Lee CY, Chang LY (2005). "Clinical management and outcome of childhood lung abscess: a 16-year experience". J Microbiol Immunol Infect. 38 (3): 183–8. PMID 15986068.
  23. Grippi, Michael (2015). Fishman's pulmonary diseases and disorders. New York: McGraw-Hill Education. ISBN 978-0071807289.
  24. Bartlett JG (1977). "Diagnostic accuracy of transtracheal aspiration bacteriologic studies". Am. Rev. Respir. Dis. 115 (5): 777–82. doi:10.1164/arrd.1977.115.5.777. PMID 857717.
  25. Bartlett JG, Mundy LM (1995). "Community-acquired pneumonia". N. Engl. J. Med. 333 (24): 1618–24. doi:10.1056/NEJM199512143332408. PMID 7477199.
  26. Case courtesy of A.Prof Frank Gaillard, <a href="https://radiopaedia.org/">Radiopaedia.org</a>. From the case <a href="https://radiopaedia.org/cases/15517">rID: 15517</a>
  27. "www.ijpsi.org" (PDF).
  28. Groff DB, Marquis J (1973). "Treatment of lung abscess by transbronchial catheter drainage". Radiology. 107 (1): 61–2. doi:10.1148/107.1.61. PMID 4689444.
  29. 29.0 29.1 Stark DD, Federle MP, Goodman PC, Podrasky AE, Webb WR (1983). "Differentiating lung abscess and empyema: radiography and computed tomography". AJR Am J Roentgenol. 141 (1): 163–7. doi:10.2214/ajr.141.1.163. PMID 6602513.
  30. Mayer, Thom (1982). "Computed Tomographic Findings of Neonatal Lung Abscess". Archives of Pediatrics & Adolescent Medicine. 136 (1): 39. doi:10.1001/archpedi.1982.03970370041010. ISSN 1072-4710.
  31. Bouhemad, Bélaïd; Zhang, Mao; Lu, Qin; Rouby, Jean-Jacques (2007). Critical Care. 11 (1): 205. doi:10.1186/cc5668. ISSN 1364-8535. Missing or empty |title= (help)
  32. Allewelt M, Schüler P, Bölcskei PL, Mauch H, Lode H (2004). "Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess". Clin. Microbiol. Infect. 10 (2): 163–70. PMID 14759242.
  33. Levison ME, Mangura CT, Lorber B, Abrutyn E, Pesanti EL, Levy RS, MacGregor RR, Schwartz AR (1983). "Clindamycin compared with penicillin for the treatment of anaerobic lung abscess". Ann. Intern. Med. 98 (4): 466–71. PMID 6838068.
  34. Germaud P, Poirier J, Jacqueme P, Guerin JC, Benard Y, Boutin C, Brambilla C, Escamilla R, Zuck P (1993). "[Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases]". Rev Pneumol Clin (in French). 49 (3): 137–41. PMID 8296141.
  35. Fernández-Sabé N, Carratalà J, Dorca J, Rosón B, Tubau F, Manresa F, Gudiol F (2003). "Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections". Eur. J. Clin. Microbiol. Infect. Dis. 22 (3): 185–7. doi:10.1007/s10096-003-0898-2. PMID 12649717.
  36. Bartlett JG (1989). "Treatment of anaerobic pulmonary infections". J. Antimicrob. Chemother. 24 (6): 836–40. PMID 2695509.
  37. Perlino CA (1981). "Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy". Arch. Intern. Med. 141 (11): 1424–7. PMID 7025777.
  38. Wunderink, R. G.; Niederman, M. S.; Kollef, M. H.; Shorr, A. F.; Kunkel, M. J.; Baruch, A.; McGee, W. T.; Reisman, A.; Chastre, J. (2012). "Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study". Clinical Infectious Diseases. 54 (5): 621–629. doi:10.1093/cid/cir895. ISSN 1058-4838.
  39. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF (2010). "Community-associated meticillin-resistant Staphylococcus aureus". Lancet. 375 (9725): 1557–68. doi:10.1016/S0140-6736(09)61999-1. PMC 3511788. PMID 20206987.
  40. 40.0 40.1 Takayanagi N, Kagiyama N, Ishiguro T, Tokunaga D, Sugita Y (2010). "Etiology and outcome of community-acquired lung abscess". Respiration. 80 (2): 98–105. doi:10.1159/000312404. PMID 20389050.
  41. 41.0 41.1 Kelogrigoris, M; Tsagouli, P; Stathopoulos, K; Tsagaridou, I; Thanos, L (2011). "Ct-guided percutaneous drainage of lung abscesses: review of 40 cases". Journal of the Belgian Society of Radiology. 94 (4): 191. doi:10.5334/jbr-btr.583. ISSN 1780-2393.
  42. vanSonnenberg E, D'Agostino HB, Casola G, Wittich GR, Varney RR, Harker C (1991). "Lung abscess: CT-guided drainage". Radiology. 178 (2): 347–51. doi:10.1148/radiology.178.2.1987590. PMID 1987590.
  43. Erasmus JJ, McAdams HP, Rossi S, Kelley MJ (2000). "Percutaneous management of intrapulmonary air and fluid collections". Radiol. Clin. North Am. 38 (2): 385–93. PMID 10765396.
  44. Hogan MJ, Coley BD (2008). "Interventional radiology treatment of empyema and lung abscesses". Paediatr Respir Rev. 9 (2): 77–84, quiz 84. doi:10.1016/j.prrv.2007.12.001. PMID 18513667.
  45. Silverman SG, Mueller PR, Saini S, Hahn PF, Simeone JF, Forman BH, Steiner E, Ferrucci JT (1988). "Thoracic empyema: management with image-guided catheter drainage". Radiology. 169 (1): 5–9. doi:10.1148/radiology.169.1.3047789. PMID 3047789.
  46. Yellin A, Yellin EO, Lieberman Y (1985). "Percutaneous tube drainage: the treatment of choice for refractory lung abscess". Ann. Thorac. Surg. 39 (3): 266–70. PMID 3977469.
  47. Wali SO, Shugaeri A, Samman YS, Abdelaziz M (2002). "Percutaneous drainage of pyogenic lung abscess". Scand. J. Infect. Dis. 34 (9): 673–9. PMID 12374359.
  48. Herth F, Ernst A, Becker HD (2005). "Endoscopic drainage of lung abscesses: technique and outcome". Chest. 127 (4): 1378–81. doi:10.1378/chest.127.4.1378. PMID 15821219.
  49. Shlomi D, Kramer MR, Fuks L, Peled N, Shitrit D (2010). "Endobronchial drainage of lung abscess: the use of laser". Scand. J. Infect. Dis. 42 (1): 65–8. doi:10.3109/00365540903292690. PMID 19883156.
  50. 50.0 50.1 Schweigert M, Dubecz A, Stadlhuber RJ, Stein HJ (2011). "Modern history of surgical management of lung abscess: from Harold Neuhof to current concepts". Ann. Thorac. Surg. 92 (6): 2293–7. doi:10.1016/j.athoracsur.2011.09.035. PMID 22115254.
  51. Refaely Y, Weissberg D (1997). "Gangrene of the lung: treatment in two stages". Ann. Thorac. Surg. 64 (4): 970–3, discussion 973–4. PMID 9354511.
  52. Chen CH, Huang WC, Chen TY, Hung TT, Liu HC, Chen CH (2009). "Massive necrotizing pneumonia with pulmonary gangrene". Ann. Thorac. Surg. 87 (1): 310–1. doi:10.1016/j.athoracsur.2008.05.077. PMID 19101324.
  53. 53.0 53.1 Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
  54. Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
  55. Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM (2005). "Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome". Radiology. 237 (1): 342–7. doi:10.1148/radiol.2371041650. PMID 16183941.
  56. 56.0 56.1 Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  57. Lee KS, Kim TS, Fujimoto K, Moriya H, Watanabe H, Tateishi U, Ashizawa K, Johkoh T, Kim EA, Kwon OJ (2003). "Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients". Eur Radiol. 13 (1): 43–51. doi:10.1007/s00330-002-1422-2. PMID 12541109.
  58. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R (2001). "Clinical characteristics of patients in a case control study of sarcoidosis". Am. J. Respir. Crit. Care Med. 164 (10 Pt 1): 1885–9. doi:10.1164/ajrccm.164.10.2104046. PMID 11734441.
  59. Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H (1989). "Pulmonary sarcoidosis: evaluation with high-resolution CT". Radiology. 172 (2): 467–71. doi:10.1148/radiology.172.2.2748828. PMID 2748828.
  60. Murphy J, Schnyder P, Herold C, Flower C (1998). "Bronchiolitis obliterans organising pneumonia simulating bronchial carcinoma". Eur Radiol. 8 (7): 1165–9. doi:10.1007/s003300050527. PMID 9724431.
  61. 61.0 61.1 Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN (2008). "Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review". Ann Thorac Med. 3 (2): 67–75. doi:10.4103/1817-1737.39641. PMC 2700454. PMID 19561910.
  62. Cordier JF, Loire R, Brune J (1989). "Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients". Chest. 96 (5): 999–1004. PMID 2805873.
  63. Lee KS, Kullnig P, Hartman TE, Müller NL (1994). "Cryptogenic organizing pneumonia: CT findings in 43 patients". AJR Am J Roentgenol. 162 (3): 543–6. doi:10.2214/ajr.162.3.8109493. PMID 8109493.
  64. Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.
  65. Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR (1989). "Pulmonary histiocytosis X: comparison of radiographic and CT findings". Radiology. 172 (1): 249–54. doi:10.1148/radiology.172.1.2787035. PMID 2787035.
  66. Andreani A, Cavazza A, Marchioni A, Richeldi L, Paci M, Rossi G (2009). "Bronchopulmonary actinomycosis associated with hiatal hernia". Mayo Clin. Proc. 84 (2): 123–8. doi:10.1016/S0025-6196(11)60819-7. PMC 2664582. PMID 19181645.
  67. Yildiz O, Doganay M (2006). "Actinomycoses and Nocardia pulmonary infections". Curr Opin Pulm Med. 12 (3): 228–34. doi:10.1097/01.mcp.0000219273.57933.48. PMID 16582679.
  68. Webb WR, Sagel SS (1982). "Actinomycosis involving the chest wall: CT findings". AJR Am J Roentgenol. 139 (5): 1007–9. doi:10.2214/ajr.139.5.1007. PMID 6981958.